'''Ixabepilone''' ([[International Nonproprietary Name|INN]]; also known as '''azaepothilone B''', codenamed '''BMS-247550''') is an [[epothilone]] B analog<ref name="pmid18463327">{{cite journal |author=Goodin S |title=Novel cytotoxic agents: epothilones |journal=Am J Health Syst Pharm |volume=65 |issue=10 Suppl 3 |pages=S10â€“5 |date=May 2008 |pmid=18463327 |doi=10.2146/ajhp080089 |url=http://www.ajhp.org/cgi/pmidlookup?view=long&pmid=18463327}}</ref> developed by [[Bristol-Myers Squibb]] as a [[chemotherapy|chemotherapeutic]] medication for cancer.<ref>http://www.cancer.org/Treatment/TreatmentsandSideEffects/GuidetoCancerDrugs/Ixabepilone</ref>
